Assessment of serum tumor markers CEA, CA-125, and CA19-9 as adjuncts in non-small cell lung cancer management
Oncotarget · 13.06.2024 · 15 (1) · 381-388
DOI: 10.18632/oncotarget.28566 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncotarget, online erschienen am 13.06.2024. Verfasst von Scott Strum und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Schulich School of Medicine and Dentistry, London, ON, Canada. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Carcinoembryonic Antigen, Lung Neoplasms, Biomarkers, Tumor. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, Schulich School of Medicine and Dentistry, London, ON, Canada.
- London Regional Cancer Program at London Health Sciences Centre, London, ON, Canada.
- Department of Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland.
Zitieren
APA
Strum, S., Vincent, M., Gipson, M., McArthur, E., & Breadner, D. (2024). Assessment of serum tumor markers CEA, CA-125, and CA19-9 as adjuncts in non-small cell lung cancer management. Oncotarget, 15(1), 381-388. https://doi.org/10.18632/oncotarget.28566
Vancouver
Strum S, Vincent M, Gipson M, McArthur E, Breadner D. Assessment of serum tumor markers CEA, CA-125, and CA19-9 as adjuncts in non-small cell lung cancer management. Oncotarget. 2024;15(1):381-388. doi:10.18632/oncotarget.28566
BibTeX
@article{Strum2024,
author = {Strum, Scott and Vincent, Mark and Gipson, Meghan and McArthur, Eric and Breadner, Daniel},
title = {Assessment of serum tumor markers CEA, CA-125, and CA19-9 as adjuncts in non-small cell lung cancer management},
journal = {Oncotarget},
year = {2024},
volume = {15},
number = {1},
pages = {381--388},
doi = {10.18632/oncotarget.28566}
}
EUVIMED